about
The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 ReactivationDrug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current conceptsFever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.Human herpesviruses 6, 7, and 8 from a dermatologic perspective.Epstein-Barr virus and skin manifestations in childhood.Human herpesvirus 6 involvement in paediatric drug hypersensitivity syndrome.Levetiracetam Induced Drug Reaction with Eosinophilia and Systemic Symptom Syndrome.Severe drug eruptions revisited.Detection of cytomegalovirus in the gastric ulcer of a patient with drug-induced hypersensitivity syndrome.Drug-Induced Hypersensitivity Syndrome Caused by Carbamazepine Used for the Treatment of Trigeminal Neuralgia.Drug reaction with eosinophilia and systemic symptoms: a clinicopathological study of six cases at a teaching hospital in midwestern Brazil.Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndrome.Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids.Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions.Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy.Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward.Drug-induced hypersensitivity syndrome by ethambutol: A case report.
P2860
Q21284983-AF30C5CF-EDF3-4F0C-A982-B39FF66B2A12Q27030788-97E9DEB1-DF70-4705-A4A0-5B32B20639A7Q27692095-125EB47E-834F-4DA2-B051-FB014D7D9EB3Q34346918-05F93225-9380-4D26-97DE-3723D4DB65ACQ34373828-71324444-6F47-4DED-9816-20C2B5C42B76Q35243378-248FAA9E-D138-41D7-AB68-B47DD9BF3524Q36755889-C50957EC-DDE0-4E77-9C07-6D87677CC139Q37992545-F14035ED-E61D-4BD6-A46B-F762BAFEB019Q39535249-8741BA2D-FE46-46D2-8B99-171CCFC087D7Q40078806-0D40B195-FCE0-437F-8F86-EAAD325E7D67Q40141051-531690E9-0015-4998-AE06-DCFD08F0A671Q40281415-27541CB4-9D17-475A-B4AA-5AA50C21426DQ40288831-844BCB5D-AE32-40F4-BB84-C76823643051Q46080278-07D8D724-540E-452E-88FD-3768910181AEQ47949008-53AEF60B-B73C-44CE-B426-B49F9F2B705BQ53111497-655DEF8C-3D91-41AE-AFA0-CF15CA594B9EQ53171269-2121FD6F-9768-4B0D-9BCC-E5E74AF5DB18
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New aspects of drug-induced hypersensitivity syndrome.
@en
New aspects of drug-induced hypersensitivity syndrome.
@nl
type
label
New aspects of drug-induced hypersensitivity syndrome.
@en
New aspects of drug-induced hypersensitivity syndrome.
@nl
prefLabel
New aspects of drug-induced hypersensitivity syndrome.
@en
New aspects of drug-induced hypersensitivity syndrome.
@nl
P2860
P1476
New aspects of drug-induced hypersensitivity syndrome.
@en
P2093
Koji Hashimoto
Mikiko Tohyama
P2860
P304
P356
10.1111/J.1346-8138.2010.01176.X
P577
2011-03-01T00:00:00Z